| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.764 | 38.711 | 34.472 | 25.471 | 21.129 | 35.221 | 77.521 | 68.114 | 63.368 | 63.901 |
| Total Income - EUR | 38.812 | 38.752 | 34.522 | 25.501 | 21.129 | 35.223 | 89.404 | 68.114 | 63.372 | 63.901 |
| Total Expenses - EUR | 22.352 | 26.498 | 34.473 | 31.012 | 27.444 | 23.321 | 48.167 | 39.398 | 44.199 | 54.749 |
| Gross Profit/Loss - EUR | 16.460 | 12.255 | 49 | -5.511 | -6.315 | 11.902 | 41.238 | 28.716 | 19.173 | 9.152 |
| Net Profit/Loss - EUR | 15.296 | 11.867 | -297 | -5.766 | -6.526 | 11.205 | 40.343 | 28.035 | 18.539 | 8.258 |
| Employees | 3 | 0 | 4 | 4 | 3 | 2 | 4 | 3 | 4 | 5 |
Check the financial reports for the company - Mosor Biovet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.614 | 29.437 | 27.954 | 27.441 | 23.013 | 32.270 | 47.555 | 47.702 | 47.558 | 47.292 |
| Current Assets | 68.158 | 70.268 | 68.915 | 59.559 | 50.728 | 56.810 | 71.440 | 41.452 | 28.988 | 33.060 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 254 | 267 | 151 | 43 | 1.971 | 49 | 8.003 | 4.343 | 8.588 | 4.188 |
| Cash | 67.903 | 70.001 | 68.764 | 59.516 | 48.757 | 56.761 | 63.437 | 37.109 | 20.400 | 28.871 |
| Shareholders Funds | 74.030 | 85.142 | 83.404 | 76.107 | 68.108 | 78.022 | 93.994 | 79.737 | 47.494 | 44.630 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.742 | 14.564 | 13.464 | 10.892 | 5.633 | 11.058 | 25.001 | 9.417 | 29.052 | 35.721 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Mosor Biovet Srl